Michel Tsimaratos

Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome

Anne‐Laure Sellier‐Leclerc, Véronique Frémeaux‐Bacchi, Marie‐Agnès Dragon‐Durey et al. · Journal of the American Society of Nephrology · 2007 · 427 citations

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

Sophie Caillard, Dany Anglicheau, Marie Matignon et al. · Kidney International · 2020 · 250 citations · Full text

Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

Jérôme Harambat, Sonia Fargue, Cécile Acquaviva et al. · Kidney International · 2009 · 151 citations · Full text

Allelic Variant, Primary Hyperoxaluria, Genetic Disorder +10

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Cécile Couchoud, Florian Bayer, Carole Ayav et al. · Kidney International · 2020 · 150 citations · Full text

Hemodialysis, Medicine, Covid-19 Pandemic +9

Safety and Efficacy of Enzyme Replacement Therapy with Agalsidase Beta: An International, Open-label Study in Pediatric Patients with Fabry Disease

J. E. Wraith, Anna Tylki‐Szymańska, Nathalie Guffon et al. · The Journal of Pediatrics · 2007 · 142 citations

Agalsidase Beta, Enzyme Replacement Therapy, Inherited Metabolic Disease +5